HistoGeneX NV Product Pipeline Analysis, 2016 Update [Updated: 30122016] Prices from USD $750

01:26 EST 1 Mar 2017 | BioPortfolio Reports


HistoGeneX NV HistoGeneX is a biotechnology company that offers clinical research services. The company offers research, clinical research and patient testing services. It handles human biological specimens and deploys technologies to interrogate the DNA, RNA and proteins to categorize, enumerate and understand cancer for research and diagnostic applications. HistoGeneX provides biomarker assay development and validation services, TMA services, skin nerve fiber assay, pathology and biomarker assessment services. It offers morphology based tests that include IHC, IF, realtime PCR, epigenetics, multianalyte IHC/IF and spectral imaging. The company offers tissue morphologybased lab research services to pharmaceutical, medical device, and academic clients. HistoGeneX is headquartered in Antwerpen, Belgium.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company HistoGeneX NV
The report provides pipeline analysis on all pipeline products of the company by equipment type, by indication, by development stage, and by trial status
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indications, applications and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials wherever applicable with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research Development strategies
Develop marketentry and market expansion strategies
Exploit inlicensing and outlicensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next highvalue products that your competitor would add in its portfolio

Original Article: HistoGeneX NV Product Pipeline Analysis, 2016 Update [Updated: 30122016] Prices from USD $750


More From BioPortfolio on "HistoGeneX NV Product Pipeline Analysis, 2016 Update [Updated: 30122016] Prices from USD $750"

Quick Search


Relevant Topics

Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...